EdgarLookup

PDS Biotechnology Corp — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Leuthner Brian A President and CEO Sale 7,500 $11.60 $87,000 252,979 Dec 1, 2016
Leuthner Brian A President and CEO Sale 7,500 $10.25 $76,875 260,479 Oct 3, 2016
MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary Purchase 9,857 $9.48 $93,444 9,857 Aug 8, 2016
Leuthner Brian A President and CEO Sale 7,500 $9.54 $71,550 267,979 Aug 1, 2016
Vaish Renu V.P., Global Reg. Affairs Option Exercise 5,000 $5.13 $25,650 5,350 Jun 16, 2016
HEALY JAMES Purchase 541,343 $7.30 $3,951,804 2,852,711 Mar 11, 2016
LOUGHLIN JAMES J Purchase 500 $7.64 $3,820 613 Mar 11, 2016
Conti Kurt G C 160,810 160,810 Oct 6, 2015
BARER SOL J C 105,319 587,810 Oct 6, 2015
LOUGHLIN JAMES J Other 364 $8.60 $3,130 19,625 Oct 6, 2015
Spiegel Robert J. Purchase 3,000 $11.00 $33,000 37,112 Oct 6, 2015
HEALY JAMES C 1,807,703 1,807,703 Oct 6, 2015
Macdonald R. Loch Chief Scientific Officer C 3,928 570,408 Oct 6, 2015
Einhorn Andrew J. Chief Financial Officer C 24,089 39,279 Oct 6, 2015
Hove Anders D Other 46,665 $8.60 $401,319 2,068,582 Oct 6, 2015
Leuthner Brian A Chief Executive Officer Other 80 $8.60 $688 550,958 Oct 6, 2015
MARCHIO ALBERT N II Chief Acct. & Op., Asst. Sec. Purchase 100 $11.00 $1,100 6,504 Oct 6, 2015
Vaish Renu V.P., Global Reg. Affairs Purchase 350 $11.00 $3,850 350 Oct 6, 2015
Faleck Herbert J Chief Medical Officer Purchase 500 $11.00 $5,500 500 Oct 6, 2015